First Trial Shows DOACs Benefit Lower-Risk Atrial Fibrillation Patients

The SINGLE-AF trial found direct oral anticoagulants reduced cardiovascular events in lower-risk atrial fibrillation patients compared to no treatment.

Carried by 2 publishers across 2 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.